MAPT and supranuclear palsy, progressive, 1: Similarly, the A152T mutation in MAPT is a risk variant for many neurodegenerative proteinopathies and has been found in cases with symptoms consistent with PSP with pallido-nigro-luysial atrophy (Graff-Radford et al., 2013; Lee et al., 2013).